Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Rühle, Alexander [VerfasserIn]   i
 Lopez Perez, Ramon [VerfasserIn]   i
 Huber, Peter E. [VerfasserIn]   i
 Nicolay, Nils [VerfasserIn]   i
Titel:The therapeutic potential of mesenchymal stromal cells in the treatment of chemotherapy-induced tissue damage
Verf.angabe:Alexander Rühle, Ramon Lopez Perez, Bingwen Zou, Anca-Ligia Grosu, Peter E. Huber, Nils H. Nicolay
E-Jahr:2019
Jahr:02 April 2019
Umfang:18 S.
Fussnoten:Gesehen am 01.07.2019
Titel Quelle:Enthalten in: Stem cell reviews and reports
Ort Quelle:New York, NY : Springer, 2009
Jahr Quelle:2019
Band/Heft Quelle:15(2019), 3, Seite 356-373
ISSN Quelle:2629-3277
Abstract:Chemotherapy constitutes one of the key treatment modalities for solid and hematological malignancies. Albeit being an effective treatment, chemotherapy application is often limited by its damage to healthy tissues, and curative treatment options for chemotherapy-related side effects are largely missing. As mesenchymal stromal cells (MSCs) are known to exhibit regenerative capacity mainly by supporting a beneficial microenvironment for tissue repair, MSC-based therapies may attenuate chemotherapy-induced tissue injuries. An increasing number of animal studies shows favorable effects of MSC-based treatments; however, clinical trials for MSC therapies in the context of chemotherapy-related side effects are rare. In this concise review, we summarize the current knowledge of the effects of MSCs on chemotherapy-induced tissue toxicities. Both preclinical and early clinical trials investigating MSC-based treatments for chemotherapy-related side reactions are presented, and mechanistic explanations about the regenerative effects of MSCs in the context of chemotherapy-induced tissue damage are discussed. Furthermore, challenges of MSC-based treatments are outlined that need closer investigations before these multipotent cells can be safely applied to cancer patients. As any pro-tumorigenicity of MSCs needs to be ruled out prior to clinical utilization of these cells for cancer patients, the pro- and anti-tumorigenic activities of MSCs are discussed in detail.
DOI:doi:10.1007/s12015-019-09886-3
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://doi.org/10.1007/s12015-019-09886-3
 DOI: https://doi.org/10.1007/s12015-019-09886-3
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:chemotherapy
 Mesenchymal stromal cells (MSCs)
 side effects
 stem cells
 tumors
K10plus-PPN:1668131293
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68402913   QR-Code
zum Seitenanfang